These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 28322587)
1. Development and Validation of Targeted Next-Generation Sequencing Panels for Detection of Germline Variants in Inherited Diseases. Santani A; Murrell J; Funke B; Yu Z; Hegde M; Mao R; Ferreira-Gonzalez A; Voelkerding KV; Weck KE Arch Pathol Lab Med; 2017 Jun; 141(6):787-797. PubMed ID: 28322587 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease. Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156 [TBL] [Abstract][Full Text] [Related]
3. Clinical validation of targeted next-generation sequencing for inherited disorders. Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102 [TBL] [Abstract][Full Text] [Related]
4. Clinical Validation of Copy Number Variant Detection from Targeted Next-Generation Sequencing Panels. Kerkhof J; Schenkel LC; Reilly J; McRobbie S; Aref-Eshghi E; Stuart A; Rupar CA; Adams P; Hegele RA; Lin H; Rodenhiser D; Knoll J; Ainsworth PJ; Sadikovic B J Mol Diagn; 2017 Nov; 19(6):905-920. PubMed ID: 28818680 [TBL] [Abstract][Full Text] [Related]
5. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038 [TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges. de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078 [TBL] [Abstract][Full Text] [Related]
10. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels. DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723 [TBL] [Abstract][Full Text] [Related]
11. Designing and Implementing NGS Tests for Inherited Disorders: A Practical Framework with Step-by-Step Guidance for Clinical Laboratories. Santani A; Simen BB; Briggs M; Lebo M; Merker JD; Nikiforova M; Vasalos P; Voelkerding K; Pfeifer J; Funke B J Mol Diagn; 2019 May; 21(3):369-374. PubMed ID: 30605766 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories. Mendez P; Dang J; Kim JW; Lee S; Yoon JH; Kim T; Sailey CJ; Jablons DM; Kim IJ Int J Oncol; 2016 Jul; 49(1):235-42. PubMed ID: 27121194 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technology. Zheng J; Zhang H; Banerjee S; Li Y; Zhou J; Yang Q; Tan X; Han P; Fu Q; Cui X; Yuan Y; Zhang M; Shen R; Song H; Zhang X; Zhao L; Peng Z; Wang W; Yin Y Mol Genet Genomic Med; 2019 Jul; 7(7):e00748. PubMed ID: 31165590 [TBL] [Abstract][Full Text] [Related]
14. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk. Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519 [TBL] [Abstract][Full Text] [Related]
15. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599 [TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients. Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243 [TBL] [Abstract][Full Text] [Related]
17. Clinical utility of a targeted next generation sequencing panel in severe and pediatric onset Mendelian diseases. Isik E; Onay H; Atik T; Canda E; Cogulu O; Coker M; Ozkinay F Eur J Med Genet; 2019 Oct; 62(10):103725. PubMed ID: 31319225 [TBL] [Abstract][Full Text] [Related]
19. Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets. Daber R; Sukhadia S; Morrissette JJ Cancer Genet; 2013 Dec; 206(12):441-8. PubMed ID: 24528889 [TBL] [Abstract][Full Text] [Related]
20. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy. Hagemann IS; Cottrell CE; Lockwood CM Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]